查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2028 年膀胱过度活动症治疗市场预测—COVID-19影响以及按药物疗法和疾病类型进行的全球分析
市场调查报告书
商品编码
1153722

2028 年膀胱过度活动症治疗市场预测—COVID-19影响以及按药物疗法和疾病类型进行的全球分析

Overactive Bladder Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Pharmacotherapy and Disease Type
出版日期: | 出版商: The Insight Partners | 英文 209 Pages | 订单完成后即时交付

价格

全球膀胱过度活动症治疗市场预计将从 2021 年的 42.9593 亿美元增长到 2028 年的 53.3392 亿美元。据估计，从 2022 年到 2028 年，复合年增长率将达到 3.1%。

膀胱过度活动症 (OAB) 是指难以控制的频繁和突然的排尿衝动。 OAB 可由腹部创伤、感染、神经损伤和某些药物引起。 OAB 在 65 岁以上的人群中很常见。女性可能在 45 岁后患上 OAB。治疗可能包括改变某些行为、药物和神经刺激。根据美国尿失禁协会的数据，2018 年全球约有 2 亿人受到尿失禁的影响。影响女性的尿失禁包括压力性尿失禁和急迫性尿失禁，后者也称为膀胱过度活动症。

同样，美国医学协会和美国传染病学会的一组研究人员在 2020 年进行的一项研究发现，美国每年约有 600 万医生因尿路感染 (UTI) 就诊。据称在加拿大，每年约有 500,000 人因 UTI 去看医生。在加拿大，尿路感染分别是就诊门诊和急诊的第八大和第五大常见原因。因此，尿失禁患病率的增加和尿路感染髮病率的增加正在推动膀胱过度活动症治疗市场。

膀胱过度活动症治疗市场分为药物疗法、疾病类型和地区。按地域划分，大致分为北美、欧洲、亚太、中东/非洲、中南美洲。膀胱过度活跃治疗市场报告重点介绍了市场趋势、市场动态和全球主要市场参与者的竞争分析等参数，提供了市场考虑和深入分析。

基于药物治疗，膀胱过度活动症治疗市场分为米拉贝隆、肉毒桿菌、神经刺激、抗胆碱能药和膀胱内滴注。米拉贝隆细分市场预计将在 2021 年占据最大的市场份额，并在预测期内实现最高的复合年增长率。米拉贝隆单独使用或与索利那新一起用于治疗成人膀胱过度活动症。它还用于治疗 3 岁及以上儿童的神经源性交叉膀胱过度活动症（一种由大脑、脊髓或神经问题引起的膀胱控制状况）。米拉贝隆属于一类称为 BETA3 肾上腺素能激动剂的药物。此药可使膀胱肌肉鬆弛，防止尿急、尿急。米拉贝隆有缓释片剂（长效）和可口服的缓释混悬剂两种形式。 2022 年 10 月，Zydus Pharmaceuticals, Inc. 获得 USFDA 的米拉贝隆缓释片 USP 25mg 和 50mg 上市许可。

COVID-19 的爆发为膀胱过度活动症治疗市场的参与者提供了几个有利的场景。美国是北美最具影响力的国家。这种传染病严重影响了该国的人口老龄化，导致各种并发症并导致许多人死亡。例如，截至 2022 年 5 月 16 日，美国报告的 COVID 病例为 84,230,829 例，死亡 1,026,670 例。因此，膀胱过度活动症的治疗和适当的护理对于预防慢性感染和疾病是必要的。

COVID-19 爆发后，膀胱过度活动症的发病率有所增加。美国泌尿外科协会的一项研究发现，感染 COVID-19 的患者出现膀胱过度活动症的新症状或症状恶化的风险增加。此外，大约三分之一的 COVID-19 患者在感染两个月后进行的国际失禁问卷调查膀胱过度活动症模块 (ICIQ-OAB) 中报告临床症状显着增加。这些患者中有三分之一，即大约五分之一，报告了 OAB 的新症状。 COVID-19导致膀胱过度活动症患病率上升，这对大流行期间膀胱过度活动症治疗的需求产生了积极影响。

在准备有关膀胱过度活动症治疗市场的报告时，主要的主要和次要来源包括世界卫生组织 (WHO)、疾病控制和预防中心 (CDC) 以及美国国务院妇女健康办公室使用了健康与公共服务。参考了以下信息：

内容

第一章介绍

  • 调查范围
  • Insight Partners 研究报告指南
  • 市场细分
    • 全球膀胱过度活动症治疗市场——药物疗法
    • 全球膀胱过度活动症治疗市场 - 按疾病类型
    • 全球膀胱过度活动症治疗市场：按地区

第 2 章膀胱过度活动症治疗的全球市场：要点

第三章研究方法论

  • 调查对象
  • 二次调查
  • 初步调查

第 4 章膀胱过度活动症治疗的全球市场：市场格局

  • 害虫分析
    • 北美 - PEST 分析
    • 欧洲 - PEST 分析
    • 亚太地区 - PEST 分析
    • 拉丁美洲 - PEST 分析
    • 中东和非洲 PEST 分析
  • 专家意见

第 5 章膀胱过度活动症治疗市场：主要市场动态

  • 市场驱动力
    • 尿失禁患病率增加
    • 增加尿路感染的发生率
  • 主要市场製约因素
    • 治疗药物召回
  • 主要市场机会
    • 併购增加
  • 未来趋势
    • 强大的药物管线和连续推出的新药
  • 影响分析

第 6 章膀胱过度活动症治疗的全球市场：全球分析

  • 膀胱过度活动症治疗全球市场收入、预测和分析
    • 膀胱过动症治疗全球市场收入预测和分析
    • 全球膀胱过度活动症治疗市场 - 市场潜力分析，按地区
    • 公司分析
  • 比较公司分析
    • 增长战略分析
    • 膀胱过度活动症治疗市场主要参与者的市场定位
      • 安斯泰来製药公司
      • Allagan PLC

第 7 章膀胱过度活动症治疗市场分析和到 2028 年的预测：药物疗法

  • 按药物疗法划分的 2021 年和 2028 年膀胱过度活动症治疗的全球市场 (%)
  • 米拉贝隆
  • 保妥适
  • 神经刺激
  • 抗胆碱药
  • 膀胱内输液

第 8 章膀胱过度活动症治疗市场分析和到 2028 年的预测：按疾病类型分类

  • 膀胱过度活动症治疗的全球市场：2021 年和 2028 年按疾病类型分类 (%)
  • 特发性膀胱过度活动症
  • 神经源性膀胱过度活动症

第 9 章膀胱过度活动症治疗市场收入和到 2028 年的预测：区域分析

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲
    • 阿联酋
    • 沙特阿拉伯
    • 南非
    • 其他中东地区
  • 拉丁美洲
      • 巴西
    • 阿根廷
      • 其他拉丁美洲

第 10 章 COVID-19 大流行对膀胱过度活动症治疗市场的影响

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第 11 章膀胱过度活动症治疗市场：行业格局

  • 市场参与者实施的增长战略 (%)
  • 有机部署

第12章公司简介

  • Alembic Pharmaceuticals Limited
  • Astellas Pharma Inc
  • AbbVie Inc
  • Teva Pharmaceutical Industries Ltd
  • Endo Pharmaceuticals Inc.
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Medtronic Plc
  • Colorado Urology Associates, PLLC
  • Axonics Modulation Technologies, Inc

第13章附录

  • 关于 Insight Partners
  • 词彙表
Product Code: TIPRE00004082

The global overactive bladder treatment market is expected to grow from US$ 4,295.93 million in 2021 to US$ 5,333.92 million by 2028. It is estimated to grow at a CAGR of 3.1% from 2022 to 2028.

Overactive bladder (OAB) is the frequent and sudden urge to urinate, which might be difficult to control. OAB can be caused due to abdominal trauma, infection, nerve damage, and certain medications. OAB is common in people aged 65 and older. Women may have OAB after 45 years. The treatment includes changing certain behaviors, medications, and nerve stimulation. According to the National Association for Incontinence data, in 2018, ~200 million people worldwide were affected by urinary incontinence. Stress incontinence and urge incontinence are the two common types of urinary incontinence affecting women, wherein the latter is also known as overactive bladder.

Similarly, a study conducted by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020 stated that urinary tract infection (UTI) was the cause of ~6 million physician visits each year in the US. In Canada, ~500,000 visits to the doctor's office are for UTI consultations annually. UTI is the eighth and fifth most common reason for ambulatory clinic visits and emergency department visits, respectively, in the country. Thus, increasing prevalence of urinary incontinence and growing incidence of urinary tract infections are driving the overactive bladder treatment market.

The overactive bladder treatment market is segmented into pharmacotherapy, disease type, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The overactive bladder treatment market report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, market dynamics, and the competitive analysis of the globally leading market players.

Based on pharmacotherapy, the overactive bladder treatment market is segmented into mirabegron, Botox, neurostimulation, anticholinergics, and intravesical instillation. The mirabegron segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR during the forecast period. Mirabegron is used alone or with solifenacin to treat overactive bladder in adults. It is used to treat neurogenic detrusor overactivity (a bladder control condition caused by the brain, spinal cord, or nerve problem) in children aged three years or more. Mirabegron belongs to the class of drugs called beta-3 adrenergic agonists. It relaxes the bladder muscles to prevent urgent, frequent, or uncontrolled urination. Mirabegron is available as an extended-release (long-acting) tablet and an extended-release suspension that can be taken orally. In October 2022, Zydus Pharmaceuticals Inc. received approval from the USFDA to market Mirabegron Extended-Release Tablets USP 25 mg and 50 mg.

The COVID-19 pandemic has shown some favorable scenarios for players operating in the overactive bladder treatment market. The US was the highly affected country in North America. The infection severely affected the geriatric population in the country, causing various complications and leading to the death of a large population. For instance, as of May 16, 2022, the US reported 84,230,829 COVID cases with 1,026,670 deaths. Therefore, overactive bladder treatment and proper care are required to prevent chronic cases of infection and health conditions.

After the COVID-19 outbreak, there has been an increase in the occurrence of OAB. According to a study by American Urological Association, patients with COVID-19 infections were at an increased risk for developing new or worsening overactive bladder symptoms. Moreover, approximately one-third of patients with COVID-19 reported a significant increase in clinical symptoms during the International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB) conducted two months after infection. Out of these one-third of patients, approximately 1 in 5 patients, reported that their OAB symptoms were new. This increased prevalence of OAB due to COVID-19 positively impacted the demand for overactive bladder treatment during the pandemic.

Some of the key primary and secondary sources referred to while preparing the report on the overactive bladder treatment market are the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the Office on Women's Health-a division of US Department of Health and Human Services, among others.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the overactive bladder treatment market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global overactive bladder treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the overactive bladder treatment market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Overactive Bladder Treatment Market- By Pharmacotherapy
    • 1.3.2 Global Overactive Bladder Treatment Market- By Disease Type
    • 1.3.3 Global Overactive Bladder Treatment Market - By Geography

2. Global Overactive Bladder Treatment Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Overactive Bladder Treatment Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 South & Central America - PEST Analysis
    • 4.2.5 Middle East & Africa - PEST Analysis
  • 4.3 Expert Opinion

5. Overactive Bladder Treatment Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increase in Prevalence of Urinary Incontinence
    • 5.1.2 Growing Incidence of Urinary Tract Infections
  • 5.2 Key Market Restraints
    • 5.2.1 Recalls of Therapeutic Drugs
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing Number of Mergers and Acquisitions
  • 5.4 Future Trends
    • 5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies
  • 5.5 Impact analysis

6. Global Overactive Bladder Treatment Market - Global Analysis

  • 6.1 Global Overactive Bladder Treatment Market Revenue Forecast and Analysis
    • 6.1.1 Global Overactive Bladder Treatment Market Revenue Forecast and Analysis
    • 6.1.2 Global Overactive Bladder Treatment Market - Market Potential Analysis, By Region
    • 6.1.3 Company Analysis
  • 6.2 Comparative Company Analysis
    • 6.2.1 Growth Strategy Analysis
    • 6.2.2 Market Positioning of Key Players in the Overactive Bladder Treatment Market
      • 6.2.2.1 Astellas Pharma Inc.
      • 6.2.2.2 Allergan Plc

7. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Pharmacotherapy

  • 7.1 Overview
  • 7.2 Global Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)
  • 7.3 Mirabegron
    • 7.3.1 Overview
    • 7.3.2 Mirabegron Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Botox
    • 7.4.1 Overview
    • 7.4.2 Botox Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Neurostimulation
    • 7.5.1 Overview
    • 7.5.2 Neurostimulation Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.5.3 Transcutaneous Sacral Nerve Stimulation
      • 7.5.3.1 Overview
      • 7.5.3.2 Transcutaneous Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.5.4 Transcutaneous Tibial Nerve Stimulation
      • 7.5.4.1 Overview
      • 7.5.4.2 Transcutaneous Tibial Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.5.5 Percutaneous Posterior Tibial Nerve Stimulation
      • 7.5.5.1 Overview
      • 7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.5.6 Others
      • 7.5.6.1 Overview
      • 7.5.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.6 Anticholinergics
    • 7.6.1 Overview
    • 7.6.2 Anticholinergics Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.3 Solifenacin
      • 7.6.3.1 Overview
      • 7.6.3.2 Solifenacin Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.4 Oxybutynin
      • 7.6.4.1 Overview
      • 7.6.4.2 Oxybutynin Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.5 Fesoterodine
      • 7.6.5.1 Overview
      • 7.6.5.2 Fesoterodine Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.6 Darifenacin
      • 7.6.6.1 Overview
      • 7.6.6.2 Darifenacin Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.7 Tolterodine
      • 7.6.7.1 Overview
      • 7.6.7.2 Tolterodine Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.8 Trospium
      • 7.6.8.1 Overview
      • 7.6.8.2 Trospium Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.9 Other Anticholinergics
      • 7.6.9.1 Overview
      • 7.6.9.2 Other Anticholinergics Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Intravesical Instillation
    • 7.7.1 Overview
    • 7.7.2 Intravesical Instillation Market Revenue and Forecast to 2028 (US$ Mn)

8. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Disease Type

  • 8.1 Overview
  • 8.2 Global Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)
  • 8.3 Idiopathic Overactive Bladder
    • 8.3.1 Overview
    • 8.3.2 Idiopathic Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Neurogenic Overactive Bladder
    • 8.4.1 Overview
    • 8.4.2 Neurogenic Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 9.1 North America: Overactive Bladder Treatment Market
    • 9.1.1 Overview
    • 9.1.2 North America: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
    • 9.1.3 North America: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
      • 9.1.3.1 North America: Overactive Bladder Treatment Market, by Anticholinergics- Revenue and Forecast to 2028 (US$ Million)
      • 9.1.3.2 North America: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
    • 9.1.4 North America: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
    • 9.1.5 North America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
      • 9.1.5.1 US: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.1 US: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.2 US: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.2.1 US: Overactive Bladder Treatment Market, by Anticholinergics- Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.2.2 US: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.3 US: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
      • 9.1.5.2 Canada: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.1 Canada: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.2 Canada: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.2.1 Canada: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.2.2 Canada: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.3 Canada: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
      • 9.1.5.3 Mexico: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.1 Mexico: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.2 Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.2.1 Mexico: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.2.2 Mexico: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.3 Mexico: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
  • 9.2 Europe: Overactive Bladder Treatment Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.3 Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.3.1 Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.3.2 Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.4 Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.5 Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
      • 9.2.5.1 UK: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.1 UK: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.2 UK: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.2.1 UK: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.2.2 UK: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.3 UK: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.2 Germany: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.1 Germany: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.2 Germany: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.2.1 Germany: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.2.2 Germany: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.3 Germany: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.3 France: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.1 France: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.2 France: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.2.1 France: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.2.2 France: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.3 France: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.4 Italy: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.1 Italy: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.2 Italy: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.2.1 Italy: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.2.2 Italy: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.3 Italy: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.5 Spain: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.1 Spain: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.2 Spain: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.2.1 Spain: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.2.2 Spain: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.3 Spain: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.6 Rest of Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.1 Rest of Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.2 Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.2.1 Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.2.2 Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.3 Rest of Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • 9.3 Asia Pacific: Overactive Bladder Treatment Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.3.3 Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
      • 9.3.3.1 Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
      • 9.3.3.2 Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    • 9.3.4 Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
    • 9.3.5 Asia Pacific: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
      • 9.3.5.1 China: overactive bladder treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.1.1 China: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.1.2 China: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.1.2.1 China: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.1.2.2 China Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.1.3 China: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.3.5.2 Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.2.1 Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.2.2 Japan: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.2.2.1 Japan: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.2.2.2 Japan Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.2.3 Japan: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.3.5.3 India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.3.1 India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.3.2 India: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.3.2.1 India: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.3.2.2 India Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.3.3 India: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.3.5.4 South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.4.1 South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.4.2 South Korea: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.4.2.1 South Korea: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.4.2.2 South Korea Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.4.3 South Korea: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.3.5.5 Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.5.1 Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.5.2 Australia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.5.2.1 Australia: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.5.2.2 Australia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.5.3 Australia: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.3.5.6 Rest of Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.1 Rest of Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.2 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.6.2.1 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.6.2.2 Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.6.3 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  • 9.4 Middle East & Africa: Overactive Bladder Treatment Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.4.3 Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
      • 9.4.3.1 Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
      • 9.4.3.2 Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    • 9.4.4 Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
    • 9.4.5 Middle East & Africa: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
      • 9.4.5.1 UAE: overactive bladder treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.1.1 UAE: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.1.2 UAE: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.4.5.1.2.1 UAE: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.4.5.1.2.2 UAE Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.1.3 UAE: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.4.5.2 Saudi Arabia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.2.1 Saudi Arabia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.2.2 Saudi Arabia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.4.5.2.2.1 Saudi Arabia: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.4.5.2.2.2 Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.2.3 Saudi Arabia: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.4.5.3 South Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.3.1 South Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.3.2 South Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.4.5.3.2.1 South Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.4.5.3.2.2 South Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.3.3 South Africa: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.4.5.4 Rest of Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.4.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.4.2 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.4.5.4.2.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.4.5.4.2.2 Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.4.3 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  • 9.5 South and Central America: Overactive Bladder Treatment Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
    • 9.5.3 South and Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
      • 9.5.3.1 South and Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
      • 9.5.3.2 South & Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    • 9.5.4 South and Central America: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)
    • 9.5.5 South and Central America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
      • 9.5.5.1 Brazil: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 9.5.5.2 Brazil: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 9.5.5.3 Brazil: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
        • 9.5.5.3.1.1 Brazil: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.5.5.3.1.2 Brazil Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
      • 9.5.5.4 Brazil: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)
    • 9.5.6 Argentina: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 9.5.6.1 Argentina: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.5.6.1.1 Argentina: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
        • 9.5.6.1.1.1 Argentina: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.5.6.1.1.2 Argentina Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.5.6.1.2 Argentina: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)
      • 9.5.6.2 Rest of South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.5.6.2.1 Rest of South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.5.6.2.2 Rest of South and Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
        • 9.5.6.2.2.1 Rest of South and Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.5.6.2.2.2 Rest of South & Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.5.6.2.3 Rest of South and Central America: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Overactive Bladder Treatment Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 South & Central America: Impact Assessment of COVID-19 Pandemic
  • 10.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

11. Overactive Bladder Treatment Market- Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Alembic Pharmaceuticals Limited
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Astellas Pharma Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 AbbVie Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Teva Pharmaceutical Industries Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Endo Pharmaceuticals Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Hisamitsu Pharmaceutical Co.,Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Medtronic Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Colorado Urology Associates, PLLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Axonics Modulation Technologies, Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Mexico: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. UK: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. UK: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. UK: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Germany: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Germany: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Germany: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Germany: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. France: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. France: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. France: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. France: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Italy: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Italy: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Italy: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Italy: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Spain: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Spain: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Spain: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Spain: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Rest of Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Asia Pacific Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. China Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. China Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. China Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. China Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Japan Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Japan Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Japan Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Japan Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. India Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. India Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. India Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. India Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. South Korea Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. South Korea Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. South Korea Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. South Korea Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Australia Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Australia Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Australia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Australia Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Rest of Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Rest of Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. Rest of Asia Pacific Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Middle East & Africa Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. UAE Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. UAE Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. UAE Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. UAE Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Saudi Arabia Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Saudi Arabia Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 83. Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 84. Saudi Arabia Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 85. South Africa Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 86. South Africa Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 87. South Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 88. South Africa Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 89. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 90. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 91. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 92. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 93. South and Central America Overactive Bladder Treatment Market, by Pharmacotherapy- Revenue and Forecast to 2028 (USD Million)
  • Table 94. South and Central America Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 95. South and Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 96. South and Central America Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (USD Million)
  • Table 97. Brazil Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (USD Million)
  • Table 98. Brazil Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 99. Brazil Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 100. Brazil Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 101. Argentina Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (USD Million)
  • Table 102. Argentina Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 103. Argentina Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 104. Argentina Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 105. Rest of South and Central America Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (USD Million)
  • Table 106. Rest of South and Central America Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 107. Rest of South and Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 108. Rest of South and Central America Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 109. Organic Developments Done by Companies
  • Table 110. Glossary of Terms

List Of Figures

  • Figure 1. Global Overactive Bladder Treatment Market Segmentation
  • Figure 2. Global Overactive Bladder Treatment Market Segmentation, By Region
  • Figure 3. Global Overactive Bladder Treatment Market Overview
  • Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in Overactive Bladder Treatment market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Overactive Bladder Treatment Market, By Geography (US$ Million)
  • Figure 7. Global Overactive Bladder Treatment Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Overactive Bladder Treatment Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. South & Central America: PEST Analysis
  • Figure 13. Middle East & Africa: PEST Analysis
  • Figure 14. Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints
  • Figure 15. Global Overactive Bladder Treatment Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 16. Global Overactive Bladder Treatment Market - Revenue Forecast and Analysis - 2021- 2028
  • Figure 17. Global Overactive Bladder Treatment Market - Market Potential Analysis, By Region
  • Figure 18. Analysis of Key Players in Overactive Bladder Treatment Market
  • Figure 19. Global Overactive Bladder Treatment Market - Comparative Company Analysis
  • Figure 20. Global Overactive Bladder Treatment Market - Growth Strategy Analysis
  • Figure 21. Global Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)
  • Figure 22. Mirabegron Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 23. Botox Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 24. Neurostimulation Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Transcutaneous Sacral Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 26. Transcutaneous Tibial Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 27. Percutaneous Posterior Tibial Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 28. Others Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 29. Anticholinergics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 30. Solifenacin Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 31. Oxybutynin Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 32. Fesoterodine Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 33. Darifenacin Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 34. Tolterodine Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 35. Trospium Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 36. Other Anticholinergics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 37. Intravesical Instillation Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 38. Global Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)
  • Figure 39. Idiopathic Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 40. Neurogenic Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 41. North America: Overactive Bladder Treatment Market Revenue Overview, By Key Country - Revenue (2021) (US$ Million)
  • Figure 42. North America: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 43. North America: Overactive Bladder Treatment Market, By Country, 2021 & 2028 (%)
  • Figure 44. US: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 45. Canada: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 46. Mexico: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 47. Europe: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 48. Europe: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
  • Figure 50. UK: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Germany: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. France: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Italy: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Spain: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Rest of Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. Asia Pacific: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 57. Asia Pacific Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 58. China: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Rest of Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Middle East & Africa: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 65. Middle East & Africa Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 66. UAE: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. Saudi Arabia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. South Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. Rest of Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. South and Central America: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 71. South and Central America Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 72. Brazil: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 73. Argentina: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 74. Rest of South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 75. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 76. Impact of COVID-19 Pandemic in European Countries Markets
  • Figure 77. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
  • Figure 78. Impact of COVID-19 Pandemic on South and Central America Country Markets
  • Figure 79. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 80. Growth Strategies Done by the Companies in the Market, (%)